Launch of Aptadir Therapeutics With a Novel Class of RNA Inhibitors
RNA Stock | USD 30.53 0.59 1.90% |
About 56% of Avidity Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Avidity Biosciences suggests that many traders are alarmed. The current market sentiment, together with Avidity Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Avidity Biosciences stock news signals to limit their universe of possible portfolio assets.
Avidity |
MILAN, September 24, 2024--Aptadir Therapeutics , a biotech company developing RNA inhibitor-based therapeutics for treating intractable cancers and genetic conditions, announces its launch and the appointment of Giovanni Amabile as Executive Chairman and acting CEO.
Read at finance.yahoo.com
![]() |
Avidity Biosciences Current Investor Sentiment
Comfort Level 44
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Avidity Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Avidity Biosciences.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Avidity Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Avidity Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Avidity Biosciences Historical Investor Sentiment
Investor biases related to Avidity Biosciences' public news can be used to forecast risks associated with an investment in Avidity. The trend in average sentiment can be used to explain how an investor holding Avidity can time the market purely based on public headlines and social activities around Avidity Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Avidity Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Avidity Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Avidity Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Avidity Biosciences.
Avidity Biosciences Maximum Pain Price Across April 17th 2025 Option Contracts
Avidity Biosciences' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Avidity Biosciences close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Avidity Biosciences' options.
Avidity Biosciences Fundamental Analysis
We analyze Avidity Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avidity Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avidity Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Avidity Biosciences is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Avidity Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avidity Biosciences stock to make a market-neutral strategy. Peer analysis of Avidity Biosciences could also be used in its relative valuation, which is a method of valuing Avidity Biosciences by comparing valuation metrics with similar companies.
Peers
Avidity Biosciences Related Equities
PLRX | Pliant Therapeutics | 2.33 | ||||
STOK | Stoke Therapeutics | 2.04 | ||||
BDTX | Black Diamond | 0.46 | ||||
RVMD | Revolution Medicines | 0.27 | ||||
IGMS | IGM Biosciences | 0.72 | ||||
RLAY | Relay Therapeutics | 1.02 | ||||
DAWN | Day One | 2.01 | ||||
SWTX | SpringWorks Therapeutics | 2.90 | ||||
MLYS | Mineralys Therapeutics, | 3.24 | ||||
ARVN | Arvinas | 3.27 | ||||
CGEM | Cullinan Oncology | 3.43 | ||||
AKRO | Akero Therapeutics | 4.32 | ||||
PASG | Passage Bio | 5.45 | ||||
PTGX | Protagonist Therapeutics | 7.10 |
Complementary Tools for Avidity Stock analysis
When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |